Robert Gaudin | Medicine and Health Sciences | Best Researcher Award

Published on by Research Awards

Best Researcher Award

Robert Gaudin
Affiliation Charité Berlin
Country Germany
Scopus ID 56119429900
Documents 41
Citations 1,949
h-index 21
Subject Area Medicine and Health Sciences
Event International Research Awards
ORCID 0000-0001-9061-7220
Robert Gaudin
Charité Berlin

The Best Researcher Award recognizes sustained scholarly excellence, impactful scientific publications, and measurable contributions to the advancement of medicine and health sciences. Robert Gaudin, affiliated with Charité Berlin, has established a recognized research profile supported by peer-reviewed publications, international collaborations, and a strong citation record indexed in Scopus. His academic portfolio demonstrates continued engagement in biomedical research and knowledge dissemination, reflecting standards commonly associated with international research recognition.[1]

Abstract

This article presents an overview of the academic achievements of Robert Gaudin within the field of medicine and health sciences. His scholarly activities include the publication of peer-reviewed research, participation in internationally recognized scientific collaborations, and contributions that have received substantial academic citations. The available bibliometric indicators demonstrate research productivity and influence consistent with internationally recognized standards of scientific excellence.[1]

Keywords

Medicine, Health Sciences, Biomedical Research, Clinical Investigation, Scientific Publications, Citation Analysis, Research Excellence, Academic Recognition

Introduction

Academic recognition awards acknowledge researchers whose work contributes significantly to scientific progress through sustained publication activity, innovation, collaboration, and scholarly influence. Bibliometric indicators such as publication count, citation performance, and the h-index are commonly considered alongside qualitative assessments of research quality and impact. Robert Gaudin’s academic profile aligns with these internationally accepted evaluation principles.[2]

Research Profile

Robert Gaudin is affiliated with Charité Berlin, one of Europe’s leading academic medical institutions. His Scopus profile records 41 indexed publications that have accumulated approximately 1,949 citations, resulting in an h-index of 21. These indicators suggest consistent scholarly productivity and a sustained influence within the biomedical research community.[1]

Research Contributions

The research contributions attributed to Robert Gaudin encompass peer-reviewed investigations, interdisciplinary collaborations, and scientific communication within medicine and health sciences. His publications contribute to expanding evidence-based knowledge while supporting international scientific dialogue. The measurable citation performance indicates that his work has been referenced by researchers across multiple studies, reflecting continued academic relevance.[1][3]

Publications

Robert Gaudin has authored and co-authored numerous peer-reviewed publications indexed in international bibliographic databases. His publication record demonstrates active participation in biomedical research and collaborative scientific projects. Several publications are associated with persistent digital object identifiers (DOIs), ensuring permanent accessibility and citation tracking across scholarly databases.[3]

Research Impact

Citation-based metrics indicate that Robert Gaudin’s research has achieved substantial visibility within the international scientific community. His h-index of 21 and citation count approaching two thousand demonstrate that multiple publications have influenced subsequent research. These bibliometric indicators are frequently considered alongside research quality, originality, and scientific significance during academic evaluation processes.[1][2]

Award Suitability

Based on publicly available bibliometric information, Robert Gaudin demonstrates characteristics commonly associated with candidates for international academic recognition. His publication record, citation performance, institutional affiliation, and continued contribution to medicine and health sciences provide objective indicators that support consideration for the Best Researcher Award presented during the International Research Awards.[1]

Conclusion

Robert Gaudin’s academic profile reflects sustained scholarly productivity, measurable citation impact, and active participation in medicine and health sciences research. His contributions illustrate the importance of rigorous scientific investigation, peer-reviewed publication, and international collaboration. Collectively, these characteristics represent the type of academic excellence recognized by international research award programs.[1]

References

  1. Elsevier. (2026). Scopus author details: Robert Gaudin, Author ID 56119429900. Scopus.https://www.scopus.com/authid/detail.uri?authorId=56119429900
  2. ORCID. (2026). Robert Gaudin ORCID Record.https://orcid.org/0000-0001-9061-7220
  3. AI-Powered Identification of Osteoporosis in Dental Panoramic Radiographs: Addressing Methodological Flaws in Current Research https://www.mdpi.com/2075-4418/14/20/2298
  4. International Research Awards. Official Award Website.https://researchawards.net/

Masahiro Tanabe | Medicine and Health Sciences | Innovative Research Award

Published on by Research Awards

Innovative Research Award

Masahiro Tanabe
Affiliation Yamaguchi University Graduate School of Medicine
Country Japan
Scopus ID 35785023100
Documents 99
Citations 740
h-index 13
Subject Area Medicine and Health Sciences
Event International Research Awards

Masahiro Tanabe

Yamaguchi University Graduate School of Medicine, Japan

The Innovative Research Award recognizes researchers whose scholarly activities demonstrate sustained scientific contributions, measurable research impact, and continued advancement within their respective disciplines. Masahiro Tanabe, affiliated with Yamaguchi University Graduate School of Medicine, has established an academic profile through peer-reviewed publications indexed in Scopus, contributing to the advancement of medicine and health sciences. His publication record, citation performance, and interdisciplinary research activities reflect consistent engagement with internationally recognized scientific literature.[1]

Abstract

Masahiro Tanabe has developed a scholarly record characterized by peer-reviewed scientific publications, measurable citation performance, and continued participation in biomedical research. His academic profile demonstrates contributions to medicine and health sciences through collaborative investigations, evidence-based methodologies, and dissemination of research findings in internationally indexed journals. Such achievements provide an objective foundation for consideration within academic recognition programs emphasizing research quality, productivity, and scientific influence.[1][2]

Keywords

Medicine, Health Sciences, Clinical Research, Biomedical Science, Translational Medicine, Peer-reviewed Publications, Citation Analysis, Research Excellence, Academic Recognition, Scopus, Evidence-based Medicine, International Research Awards.

Introduction

Academic awards acknowledge sustained scientific excellence through objective indicators such as publication quality, citation performance, collaboration, and research relevance. Within medicine and health sciences, scholarly contributions support evidence-based healthcare, clinical innovation, and interdisciplinary scientific advancement. Researchers demonstrating continuous publication activity and measurable academic influence contribute significantly to the global scientific community.[3]

Research Profile

Masahiro Tanabe is affiliated with the Yamaguchi University Graduate School of Medicine, Japan. According to the available Scopus author profile, the researcher has produced 99 indexed publications that have collectively received approximately 740 citations and achieved an h-index of 13. These indicators represent sustained scholarly productivity and continuing engagement with international scientific literature.[1]

Research Contributions

The research activities associated with Masahiro Tanabe emphasize scientific investigation within medicine and health sciences. Publications have contributed to expanding biomedical knowledge through clinical and translational research, collaborative studies, and dissemination of evidence supporting improved healthcare practices. Continued publication activity indicates active participation in advancing scientific understanding within the international medical research community.[2]

Publications

The available bibliometric record identifies 99 Scopus-indexed publications. The publication portfolio demonstrates consistent scholarly communication through peer-reviewed journals and collaborative research. Indexed publications remain a widely accepted measure of scientific productivity and international academic visibility.[1]

Research Impact

Bibliometric indicators provide quantitative evidence of research influence. Approximately 740 citations and an h-index of 13 indicate that multiple publications have received sustained scholarly attention within the scientific community. Citation metrics complement peer review by demonstrating continued utilization and recognition of published research.[1][3]

Award Suitability

Based on publicly available bibliometric indicators and institutional affiliation, Masahiro Tanabe demonstrates characteristics commonly evaluated within international research recognition programs. These include sustained publication output, measurable citation impact, scientific collaboration, and continued contributions to medicine and health sciences. Such objective academic indicators align with evaluation principles commonly applied by research award committees.[1]

Conclusion

Masahiro Tanabe’s scholarly profile reflects sustained participation in biomedical research supported by internationally indexed publications and measurable citation performance. The combination of publication productivity, academic influence, and institutional affiliation illustrates continued engagement in advancing medicine and health sciences. These characteristics provide an objective basis for consideration within academic recognition initiatives such as the International Research Awards.[1]

References

  1. Elsevier. (2026). Scopus author details: Masahiro Tanabe, Author ID 35785023100. Scopus.https://www.scopus.com/authid/detail.uri?authorId=35785023100
  2. Masahiro Tanabe, (2026). Digital Object Identifier (DOI) System.https://www.mdpi.com/2379-139X/12/6/84
  3. International Research Awards.(2026). https://researchawards.net/

Ute Botzenhart | Medicine and Health Sciences | Research Excellence Award

Published on by Research Awards

Dr. Ute Botzenhart | Orthodontics | Research Excellence Award 

Dresden University of Technology | Germany

Dr. Ute Ulrike Botzenhart is a highly accomplished orthodontist and researcher with extensive expertise in dental medicine, craniofacial biology, and functional orthodontics. Affiliated with TU Dresden and actively engaged in international collaboration with the University of Poznan, her research focuses on the interplay between muscle function and the stomatognathic system, with particular emphasis on innovative therapeutic interventions such as botulinum toxin applications. Her doctoral and habilitation work reflects a strong foundation in both experimental and clinical research, including studies on laser applications in dentistry and functional modulation of oral structures. Dr. Botzenhart integrates advanced digital orthodontic technologies with evidence-based clinical practice, contributing to improved diagnostic and treatment outcomes. She is actively involved in teaching, project management, and interdisciplinary research, while maintaining clinical excellence in orthodontic care. Her memberships in leading professional societies and certifications in areas such as dental sleep medicine, sports dentistry, and digital volume tomography further highlight her commitment to continuous professional development and innovation in modern orthodontics.

Citation Metrics (Google Scholar)

  600
  500
  400
  300
  200
    50
     30
     10
       0

Citations
563

Documents
47

h-index
15

Citations

h-index

i10-index

View Google Scholar Profile
     View Scopus Profile

Featured Publications

Junning Ma | Medicine and Health Sciences | Young Scientist Award

Published on by Research Awards

Dr. Junning Ma | Medicine and Health Sciences | Young Scientist Award

Zhejiang University and Qing Hai University | China

Ma Juning is a clinician-scientist specializing in neurosurgery with a strong focus on nanomedicine and targeted therapies for neurological disorders. His research centers on engineering biomimetic nanoparticles and cell membrane-coated nanocarriers to improve drug delivery across complex biological barriers, particularly in glioma, stroke, and pituitary adenomas. He has led competitive projects funded by the National Natural Science Foundation of China and the China Postdoctoral Science Foundation, highlighting his capacity for independent and innovative research. His international training, including a joint doctoral program at Yale University, has strengthened his expertise in translational neuroscience and advanced therapeutic strategies. Dr. Ma has contributed to high-impact publications in leading journals such as Biomaterials, Nano Letters, and Materials Today Bio, reflecting the significance of his work in tumor microenvironment targeting and immunotherapy. His interdisciplinary background integrates neurosurgery, nanotechnology, and stem cell research, aiming to develop clinically viable solutions for challenging brain diseases. In addition to research, he demonstrates leadership through active roles in academic and clinical communities. With a solid foundation in both basic science and clinical practice, he continues to advance precision medicine approaches for neurological disease treatment.

Citation Metrics (Scopus)

  500
  400
  300
  200
    50
     30
     10
       0

Citations
422

Documents
8

h-index
8

Citations

h-index

i10-index

View Scopus Profile
     View orcid Profile

Featured Publications

Marco Miceli | Biology and Life Sciences | Best Paper Award

Published on by Research Awards

Dr. Marco Miceli | Biology and Life Sciences | Best Paper Award 

CEINGE-Biotecnologie Avanzate Franco Salvatore | Italy

Dr. Marco Miceli is an Italian biomedical researcher with over two decades of continuous experience in molecular biology, epigenetics, genetics, and translational biomedical research, developed within leading academic and research institutions in Italy. Born on 20 February 1973, he is currently engaged at CEINGE–Biotecnologie Avanzate “Franco Salvatore” in Naples, where since October 2022 he has been working under a fixed-term collaboration contract within the national project “TASK FORCE 2022 COVID-19”. In this role, he serves as Head of the Level III Biosafety Laboratory (BSL-3), operating under the scientific supervision of Prof. Massimo Zollo, with responsibilities encompassing high-containment laboratory management, advanced virological research, and biosafety compliance. Between 2020 and 2022, Dr. Miceli worked at the University of Naples Federico II, Department of Neurosciences, Reproductive Sciences and Odontostomatology, contributing to a CDA-funded project focused on the molecular etiology of syndromic and non-syndromic genetic hearing loss, including genotype–phenotype correlations and functional characterization of pathogenic variants. His research career has been strongly rooted at CEINGE and associated institutes, where he has held multiple research appointments since 2019, collaborating on projects spanning molecular diagnostics, functional genomics, and advanced cellular models. Earlier in his career, he served as a fixed-term researcher at the IRCCS SDN Research Institute, working on innovative projects involving amniocyte stem cells, 3D scaffolds for bone tissue engineering, and epigenetic profiling of immune cells in metabolic disorders. From 2005 onward, Dr. Miceli played a sustained role in several nationally and EU-funded research programs, including EPITRON, ATLAS, APO-SYS, and PON-SIRTT-IN, primarily under the scientific guidance of Prof. Lucia Altucci. His work during this period focused on epigenetic regulation of gene expression, chromatin immunoprecipitation (ChIP), real-time PCR, histone deacetylase complexes, apoptosis regulation, and cancer epigenetics. Dr. Miceli’s long-standing expertise spans molecular genetics, chromatin biology, lentiviral systems, stem cell models, and translational biomedical research, making him a highly experienced and reliable contributor to multidisciplinary research initiatives at the interface of basic science, clinical research, and advanced biotechnological applications.

Citation Metrics (Google Scholar)

3000
2000
1000
500
400
300
200
100
50
30
10
0

Citations
2756

Documents
39

h-index
25

Citations

Documents

h-index

View Google Scholar Profile
   View Orcid Profile

Featured Publications

Hou-Qun Ying | Toxicology and Pharmaceutical Science | Research Excellence Award

Published on by Research Awards

Prof. Hou-Qun Ying | Toxicology and Pharmaceutical Science | Research Excellence Award 

The Second Affiliated Hospital of Nanchang University | China

Dr. Hou-Qun Ying, PhD, born on July 18, 1985, in Shangrao, Jiangxi Province, China, is an accomplished clinical scientist specializing in cancer biomarkers, inflammation-related indices, molecular epidemiology, and therapeutic response prediction. He currently serves as the Vice Director of the Department of Clinical Laboratory Medicine at The Second Affiliated Hospital of Nanchang University, where he plays a leading role in translational research, diagnostic innovation, and clinical laboratory management. Dr. Ying earned his Ph.D. in Clinical Laboratory Diagnosis from Southeast University (2013–2016), after completing his Master of Medicine in Pathogenic Biology at Dali University and his Bachelor of Medicine in Medical Laboratory Science from Tianjin Medical University. His academic and professional journey reflects strong expertise in cancer diagnostics, genetic polymorphisms, biomarker development, and precision medicine. Dr. Ying has successfully led multiple competitive research grants, including the National Natural Science Foundation of China Youth Fund (2018–2020), exploring Hippo-pathway-related genetic variations and EGFR-TKI resistance in non-small cell lung cancer, and the 2024–2027 Regional Fund focusing on SP1 transcription factor–related genetic variations as biomarkers for bevacizumab resistance in metastatic colorectal cancer. His research contributions span more than 70 peer-reviewed publications, with many as first, co-first, or corresponding author in high-impact journals such as Scientific Reports, Oncotarget, Cancer Medicine, Therapeutic Advances in Medical Oncology, Frontiers in Oncology, Pharmacological Research, Biomarkers, Future Oncology, and J Inflammation Research. His studies have provided pivotal insights into inflammatory markers such as fibrinogen-to-pre-albumin ratio, albumin-to-fibrinogen ratio, dNLR, PLR, and novel composite biomarkers for cancer prognosis, treatment response prediction, early diagnosis, and recurrence risk stratification. He has also made influential contributions to colorectal cancer, gastric cancer, gallbladder carcinoma, hepatocellular carcinoma, and NSCLC through biomarker innovation, clinical prediction models, and meta-analytic evaluations. As a corresponding author, Dr. Ying has developed and validated numerous inflammation-based and genetic biomarker signatures, such as FPR, ADS score, MLPAS, CCMLP, and chronic inflammation indices, improving precision therapeutic decisions for chemotherapy, bevacizumab, 5-FU–based regimens, and TKIs. Additionally, his collaborative work extends to machine learning applications in early gastric cancer prediction, molecular mechanisms underlying cancer progression, and multi-omics approaches. With a distinguished record of scientific leadership, grant success, and impactful publications, Dr. Ying continues to advance clinical oncology diagnostics and personalized treatment strategies through rigorous research, innovation, and interdisciplinary collaboration.

Profiles: Scopus | Orcid

Featured Publications

Peng, Y., Shang, R., Wang, Z.-J., Ye, Q.-Y., Tang, X.-Y., Cheng, X.-X., & Ying, H.-Q. (2025). Chronic inflammatory comprehensive signature predicts oxaliplatin and 5-fluorouracil benefit in early colorectal cancer. Drug Design, Development and Therapy. https://doi.org/10.2147/DDDT.S556619

Lu, Y., Ye, Q.-Y., Mei, O., Li, Y.-N., Peng, Y., Ying, H.-Q., & Cheng, X.-X. (2025). Chronic inflammation index-based tumor subsite classification correlated with chemotherapy benefit and survival outcomes in stage II–III colorectal cancer. Journal of Inflammation Research. https://doi.org/10.2147/JIR.S517378

Ye, Q.-Y., Wang, Y.-Y., Wang, Z.-J., Lu, M., Peng, H.-X., Wang, X., Cheng, X.-X., & Ying, H.-Q. (2025). Robust predictive performance of MLPAS and CCMLP for clinical outcome and risk stratification in patients with colorectal cancer. Journal of Inflammation Research. https://doi.org/10.2147/JIR.S498028

Tian, H., Liu, Z., Zhang, Z., Zhang, L., Zong, Z., Liu, J., Ying, H., & Li, H. (2023). Clinical significance of fibrinogen and platelet to pre-albumin ratio in predicting the prognosis of advanced gastric cancer. Journal of Inflammation Research. https://doi.org/10.2147/JIR.S412033

Ying, H.-Q., Liao, Y.-C., Luo, Y.-R., Xiong, G., Huang, Y., Nie, R.-W., Xiong, C.-F., & Cheng, X.-X. (2021). Cancer-elicited inflammation attenuates response and outcome in tyrosine kinase inhibitor naïve patients with advanced NSCLC. Pharmacological Research, 105734. https://doi.org/10.1016/j.phrs.2021.105734

Ying, H.-Q., You, X.-H., Liao, Y.-C., Sun, F., & Cheng, X.-X. (2021). High-grade inflammation attenuates chemosensitivity and confers poor survival of surgical stage III CRC patients. Frontiers in Oncology, 11, 580455. https://doi.org/10.3389/fonc.2021.580455

Liao, Y.-C., Ying, H.-Q., Huang, Y., Luo, Y.-R., Xiong, C.-F., Nie, R.-W., Li, X.-J., & Cheng, X.-X. (2021). Role of chronic inflammatory ratios in predicting recurrence of resected patients with stage I–III mucinous colorectal adenocarcinoma. Cancer Management and Research, 13, 303758. https://doi.org/10.2147/CMAR.S303758

Yves Julien Mbama Biloa | Medicine and Health Sciences | Young Scientist Award

Published on by Research Awards

Mr. Yves Julien Mbama Biloa | Medicine and Health Sciences | Young Scientist Award 

Jean Monnet University | France

Mr. Yves Julien MBAMA BILOA is a dedicated emerging public health scholar whose research, teaching, and professional work converge around preventive health, clinical innovation, and population well-being. Born on May 16, 1996, in Cameroon, he is currently completing his Ph.D. in Public Health at Jean Monnet University of Saint-Étienne, France, where he will defend his doctoral thesis on December 18, 2025. His doctoral research—focused on developing a preventive clinical practice framework during the transition to retirement using the Delphi consensus method—positions him at the forefront of preventive healthcare innovation for aging populations. With a strong academic foundation in human biology, animal physiology, and epidemiology, he holds a Master’s degree in Biology and Physiology of Animal Organisms (2021) and a Bachelor’s degree in Human Biology and Health, both from the University of Douala, Cameroon. His expertise extends across qualitative and quantitative research methods, statistics, health promotion, and digital health applications. Yves has developed a robust professional background that includes university-level teaching, research contributions, and entrepreneurial experience. As a Public Health Teacher at Université Claude Bernard Lyon 1 and IRFSS-FI Rhône Alpes, he has delivered courses on social inequalities in health, nursing practices, and international mobility, shaping the perspectives of future healthcare professionals. His entrepreneurial initiative as the Founder of the Center for Statistical Processing and Analysis in Douala demonstrates his leadership in offering methodological support, statistical consulting, and academic mentorship to students and researchers. His skill set spans statistical analysis, epidemiological assessment, scientific writing, and the application of artificial intelligence in health. His publication record reflects growing expertise in preventive healthcare, retirement-transition health strategies, and emerging health challenges. He has authored and co-authored peer-reviewed articles in reputable journals such as Public Health, Journal of Public Health (Berlin), BMC Infectious Diseases, and Journal of Health, Population and Nutrition. His works include a Delphi-based preventive clinical practice framework, a scoping review on periodic health examinations during retirement transition, a mixed-methods protocol for evaluating Long Covid interventions (SPACO+), and studies on cardioprotective effects of methotrexate and metabolic syndrome among students. His research aims to strengthen health systems, empower healthcare decision-making, and enhance preventive care models, especially within the contexts of aging, chronic diseases, and digital health transformation. After completing his Ph.D., he intends to advance his expertise in health prevention, mental health, digital health, and health system improvement, contributing impactful and evidence-based insights to global public health

Profiles: Scopus | Orcid

Featured Publications

Development of a preventive clinical practice framework for transition to retirement

Mbama Biloa, Y. J., Rozand, V., Oriol, M., Guindo, Y., Botelho-Nevers, E., & Bongue, B. (2025). Development of a preventive clinical practice framework for transition to retirement: A Delphi consensus of French physicians. Public Health, 249, 106003.

SPACO+: A mixed methods protocol for assessing the effectiveness of an educative intervention in patients with Long Covid

Kamdem, O. L., Dupre, C., Heugno, V., Baudot, A., Essangui, E., Blanquet, M., Guercon, N., Fanget, M., Bayet, S., Vericel, M. P., et al., & Mbama Biloa, Y. J. (2025). SPACO+: A mixed methods protocol to assessing the effectiveness of an educative intervention in patients with Long Covid. BMC Infectious Diseases, 25, 623.

Periodic health examination during transition to retirement: A scoping review

Mbama Biloa, Y. J., Rozand, V., Kamdem, L., Regnier-Denois, V., Botelho-Nevers, E., & Bongue, B. (2025). Periodic health examination during transition to retirement: A scoping review. Journal of Public Health (Berlin).

Unveiling the hidden shield: Methotrexate as a cardio-protector in psoriasis

Mai, S., Mbama, Y., Gouttefarde, P., Franck, T., Cizeron, G., Oriol, M., Maccari, F., Trombert, B., Bongué, B., & Perrot, J.-L. (2024). Unveiling the hidden shield: Methotrexate emerges as a cardio-protector in psoriasis—Insights from a scoping review [Preprint]. HAL Archive.

Prevalence of metabolic syndrome and components in rural, semi-urban, and urban areas in Cameroon

Bilog, N. C., Mekoulou Ndongo, J., Bika Lele, E. C., Guessogo, W. R., Assomo-Ndemba, P. B., Ahmadou, … Mbama Biloa, Y. J., … Temfemo, A. (2023). Prevalence of metabolic syndrome and components in rural, semi-urban and urban areas in the littoral region in Cameroon: Impact of physical activity. Journal of Health, Population and Nutrition, 42, 95.

Jing Li | Engineering | Research Excellence Award

Published on by Research Awards

Prof Dr. Jing Li | Engineering | Research Excellence Award

Shenyang University of Technology | China

Dr. Jing Li is a distinguished Professor and Ph.D. Supervisor at Shenyang University of Technology, specializing in electrical machines and apparatus, arc physics, gas-discharge theory, and simulation modeling. With a career dedicated to advancing the science behind electrical switching devices and circuit protection, her research integrates theoretical modeling, experimental validation, and engineering application—particularly in areas involving complex arc discharge dynamics, thermal behavior, and switching reliability of electrical apparatus under extreme operating conditions. Dr. Li has made substantial contributions to the understanding of arc interruption mechanisms, arc-fluid interaction phenomena, contact erosion processes, and high-altitude circuit breaker behavior, addressing pressing challenges relevant to next-generation power systems, high-voltage DC applications, and emerging smart-grid infrastructure. Her research excellence is demonstrated through her role as Principal Investigator for major funded programs, including one National Natural Science Foundation of China (NSFC) project, one province-level major R&D initiative, and six general research projects supported by government science and education agencies. Additionally, she has participated in more than twenty national, provincial, and collaborative research grants, highlighting her strong research leadership and interdisciplinary engagement within China’s advanced electrical engineering research ecosystem. Dr. Li’s achievements have been recognized through numerous prestigious honors, including the Mechanical Science and Technology Progress Award (Second and Third Prizes) and the Liaoning Science and Technology Progress Award (Second Prize). Dr. Li has authored more than 40 peer-reviewed journal papers, with publications appearing in high-impact international and national journals such as the Chemical Engineering Journal, International Journal of Thermal Sciences, Physics of Fluids, Chinese Physics B, Plasma Science and Technology, Proceedings of the CSEE, and Transactions of the China Electrotechnical Society. Her most recent work includes advanced modeling of arc formation, droplet splashing behavior, fluid-chemical coupling during current interruption, and structural improvements in circuit breaker performance, reflecting deep insight into plasma-material interaction and multiphysics coupling. In addition to her research, Dr. Li serves as a reviewer for leading journals including Physics of Fluids, Proceedings of the CSEE, and Electrical Appliances & Energy Efficiency Management, demonstrating her recognition as a leading expert in the field. Through her scholarly work, project leadership, and contributions to scientific evaluation, Professor Jing Li continues to play a pivotal role in advancing the science and engineering of modern electrical protection systems and applied plasma physics.

Profiles: Scopus | Orcid

Featured Publications

Duan, W., Li, J., Yang, J., Huang, C., Fu, S., Li, Z., & Li, T. (2025). Experimental and numerical study of metal droplet splashing effects on direct current air arc interruption. Physics of Fluids. https://doi.org/10.1063/5.0288531

Duan, W., Li, J., Gao, W., Shi, B., Liu, S., & Cao, Y. (2025). Investigation on heat transfer and fluid flow of arc-flash phenomenon in DC molded case circuit breakers: Model optimization and structural improvement. International Journal of Thermal Sciences. https://doi.org/10.1016/j.ijthermalsci.2025.109919

Xing, C., Liu, S., Li, Y., Xu, J., & Li, J. (2025). Degradation stage division and identification of AC contactor’s contact system. IEEE Sensors Journal. https://doi.org/10.1109/JSEN.2025.3527471

Duan, W., Li, J., Bao, Y., Huang, H., Yang, J., Liu, S., & Cao, Y. (2025). Interaction between arc root stagnation-transition and contact erosion during direct current air circuit breaker interruption. Physics of Fluids. https://doi.org/10.1063/5.0239389

Li, J., Yin, Y., Peng, S., Liu, S., Fu, Y., & Yu, L. (2025). The improvement of self-excited small current breaking of SE-DCCB by magnetic field reconstruction based on the evolution mechanism of arc root transition. Physics of Plasmas. https://doi.org/10.1063/5.0230317

Peng, S., Li, J., Liu, S., & Cao, Y. (2024). Research on the liquid metal bridge formation process at contact separation moment of DC air circuit breaker. IEEE Transactions on Plasma Science. https://doi.org/10.1109/TPS.2024.3357755

Li, J., Peng, S., Yi, C., Huang, H., Cao, Y., Liu, S., & Zhou, Z. (2024). Optimization research on DC air circuit breaker at high altitudes based on arc root stagnation and arc reverse movement phenomena. Journal of Electrical Engineering & Technology. https://doi.org/10.1007/s42835-023-01633-6

 

Thierry Ngouana Kammalac | Medical Mycology | Best Research Article Award

Published on by Research Awards

Dr. Thierry Ngouana Kammalac | Medical Mycology | Best Research Article Award

Laboratoire Sion| Cameroon

Dr. Ngouana Kammalac Thierry is an accomplished Cameroonian biochemist and medical mycologist with extensive experience in microbial diagnostics, infectious disease research, and biotechnology innovation. He holds a PhD in Biochemistry and Health Sciences (2014), jointly awarded by the University of Montpellier in France and the University of Yaoundé I in Cameroon, where his doctoral work focused on the genetic diversity of Cryptococcus and Candida isolates in HIV-positive patients and their susceptibility to antifungal therapies and medicinal plant extracts. He also holds a Master’s degree in Biochemistry (2009) from the University of Yaoundé I. Dr. Ngouana has built an exceptional career at the intersection of laboratory science, diagnostic technology, and academic instruction. As Director of Zion Biomedical Corporation since 2023, he leads the development and large-scale production of innovative biomedical products, including lateral flow immunochromatographic diagnostic tests, microbial culture media, and specialized staining dyes, contributing to improved diagnostic capacities in the region. Since 2016, he has also served as Director of Zion Medical Laboratory, where he oversees scientific development, clinical diagnostics, and antimicrobial resistance surveillance. His laboratory plays a crucial role in cryptococcal meningitis diagnosis among HIV-infected patients, the establishment of microbial standard operating procedures (SOPs), and the strengthening of Cameroon’s diagnostic infrastructure. Alongside his laboratory leadership, Dr. Ngouana has been an associate lecturer at the Catholic University and the Protestant University of Central Africa since 2015, teaching courses in medical mycology, biochemistry, and bacteriology. He has a strong publication record, contributing to high-impact research on Candida genetic diversity, antifungal resistance, pathogenic yeast epidemiology, and bioactive compounds from medicinal plants. His work has appeared in reputable journals such as Brazilian Journal of Microbiology, American Journal of Microbiological Research, Mycoses, Journal de Mycologie Médicale, Medical Mycology, and Journal of Medical Microbiology. Notable contributions include studies revealing novel genotypes of Candida species, antifungal susceptibility patterns in Africa and Europe, and plant-derived compounds with potent antifungal activity. Dr. Ngouana’s expertise spans molecular diagnostics, PCR, microscopy, microbial culture, infection control, and data analysis, supported by strong research methodology and teamwork competencies. He is an active member of the FAILSAFE Medical Mycology Network, the Cameroonian Society of Microbiology, and the French Society of Medical Mycology, reflecting his engagement in global scientific collaboration and capacity building in medical mycology.

Profiles: Scopus | Orcid

Featured Publications

Ngouana, T. K., Dougue, A. N., Ngouana, V., Tsayem, R. F., Mahamat, Y. H., Boyom, F. F., & Ranque, S. (2025). Vulvo-vaginal candidiasis at the Zion Clinical Laboratory (Yaounde-Cameroon): Risk factors, species distribution and antifungal susceptibility testing. Journal of Medical Mycology,

Kountchou, C. L., Kabtani, J., Dougue, A. N., Nangwat, C., Ekpo, A. I., Ngonde, M. C., Mogo, C. B., Dzoyem, J. P., Ranque, S., & Ngouana, T. K. (2025). Candida krusei (Pichia kudriavzevii) multilocus sequence typing and antifungal susceptibility profile in Cameroon. Brazilian Journal of Microbiology.

Medhat Elshahat | Genetics and Genomics | Editorial Board Member

Published on by Research Awards

Mr. Medhat Elshahat | Genetics and Genomics | Editorial Board Member

Bari University | Italy

Mr. Medhat Saleh is an accomplished researcher and academic specializing in Poultry Breeding and Genetics, currently pursuing his Ph.D. at the Department of Veterinary Medicine, University of Bari “Aldo Moro”, Italy. He also serves as an Assistant Lecturer of Poultry Breeding and Genetics at the Faculty of Agriculture, Benha University, Egypt. His professional journey reflects a consistent commitment to advancing the fields of quantitative genetics, genomics, animal breeding, and bioinformatics, with a particular emphasis on understanding the genetic architecture of complex traits and genomic diversity in livestock species. Mr. Saleh obtained his B.Sc. in Agricultural Science (Animal Production) in 2015 and an M.Sc. in Agricultural Biotechnology in 2019 through a collaborative program between Benha University and the TEMPUS European Union Project. His academic excellence earned him a Ph.D. scholarship at the University of Bari in 2021, where his research focuses on genome-wide association studies (GWAS) and the identification of SNPs and functional genes linked to economically significant traits in poultry. His recent visiting research experience at Wageningen University, the Netherlands (2023–2024), further expanded his expertise in animal breeding and genomics. Throughout his career, Mr. Saleh has actively participated in international conferences and workshops across Italy, Germany, Egypt, and the Netherlands, contributing to scientific discussions on genomic selection, precision livestock farming, and sustainable animal production. His publication record includes numerous peer-reviewed articles in high-impact journals such as British Poultry Science, Livestock Science, and Poultry Science Journal, covering topics like molecular genetics, bioinformatics analyses, and crossbreeding impacts on immunity and growth traits in chickens. Technically proficient, he is skilled in molecular and bioinformatics techniques, including DNA/RNA extraction, PCR, and advanced data analysis using Plink, R, SAS, BLUPF90, and GENALEX. His collaborative research efforts with international scientists underscore his analytical and problem-solving abilities. Mr. Saleh’s professional strengths also encompass strategic planning, critical thinking, teamwork, and communication, enabling him to contribute effectively to academic and applied research environments. With a strong dedication to scientific advancement and sustainable genetic improvement in poultry, Mr. Saleh aims to bridge genomic innovation and animal production for future generations. His growing global research profile positions him as a promising young scientist contributing significantly to the fields of animal genetics, breeding, and biotechnology.

Profiles: Orcid | Google Scholar

Featured Publications

Galgano, M., Pellegrini, F., Fracchiolla, G., Mrenoshki, D., Zarea, A. A. K., Bianco, A., Del Sambro, L., Capozzi, L., Schiavone, A., & Saleh, M. S. (2023). Pilot study on the action of Thymus vulgaris essential oil in treating the most common bacterial contaminants and Salmonella enterica subsp. enterica serovar Derby in poultry litter. Antibiotics, 12(3), 436.

Saleh, M. S., Iraqi, M. M., Khalil, M. H., & Camarda, A. (2020). Crossbreeding analyses and polymorphic associations of gallinacin genes with growth traits in chickens. Livestock Science, 240, 104118.

Saleh, M. S. (2019). Using bioinformatics SNP to improve immune genetic response against some pathogens in poultry. [Master’s thesis, Benha University, in cooperation with TEMPUS European Union Program].

Saleh, M. S., Khalil, M. H., Iraqi, M. M., & Camarda, A. (2021). Polymorphic characterization of gallinacin candidate genes and their molecular associations with growth and immunity traits in chickens. British Poultry Science, 62(2), 180–187.

Pugliese, N., Tinelli, A., Crescenzo, G., Nieddu, M., Baralla, E., Schiavone, A., Zizzo, N., Samarelli, R., Dessì, F., Circella, E., & Saleh, M. S. (2024). Poisoning by Nerium oleander L. in Franconia geese. Animals, 14(4), 612.

Saleh, M. S., Khalil, M. H., Iraqi, M. M., & Camarda, A. (2021). Molecular associations of gallinacin genes with immune response against Salmonella typhimurium in chickens. Livestock Science, 244, 104315.

Saleh, M. S., Landi, V., Derks, M. F. L., Centoducati, G., Groenen, M. A. M., De Palo, P., Ciani, E., Pugliese, N., Circella, E., & Camarda, A. (2025). Genome-wide analyses of genomic diversity, population structure and selection signatures in Italian turkey populations. Poultry Science, 104(1), 104543.